Released On: November 22, 2024
Expires On: November 22, 2025
Jointly provided by Consortium of Multiple Sclerosis Centers (CMSC) and PlatformQ Health Education, LLC (PQHE).
ACKNOWLEDGEMENT
This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.
TUITION
No fee is required for this program
DATE OF RELEASE/EXPIRATION
The enduring material will be available from November 22, 2024 to November 22, 2025.
TARGET AUDIENCE
This activity has been designed to meet the educational needs of advanced practice clinicians (NP/PA) and nurses involved in the care of people with MS.
LEARNING OBJECTIVES
Upon completing this activity, participants should be better able to:
- Apply the most recent McDonald criteria for MS diagnosis when evaluating patients with symptoms suggestive of MS
- Summarize mechanisms of action and latest safety and efficacy data of DMTs for MS
- Discuss the roles of APCs and nurses in a patient-centered approach to therapy selection, monitoring patient response to therapy, and mitigating treatment-related adverse events in MS
- Describe how APCs and nurses are in a unique position to provide equitable MS care to patients from underserved communities and apply strategies to provide individualized, holistic, patient-centered care, including mental health considerations
ACCREDITATION AND CREDIT DESIGNATION
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and PlatformQ Health Education, LLC. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses
The CMSC designates this activity for a maximum of 0.75 Nursing Continuing Professional Development (NCPD) credits (0.5 in the area of pharmacology)
Physicians
The Consortium of Multiple Sclerosis Centers designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance for Other Healthcare Professionals
A Certificate of Attendance will be given upon completion of course requirements enabling participants to register their credit with the appropriate licensing boards or associations. Participants may apply for other accreditations using procedures established by specific organizations.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Continuing Education, CMSC and PQHE require that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies. CMSC and PQHE mitigate all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, CMSC and PQHE seek to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC and PQHE are committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.
FACULTY DISCLOSURES
Christine Marcello, MSN, FNP-BC, MSCN served as faculty for this activity. She has disclosed no relevant financial relationships.
STAFF DISCLOSURES
The planners, reviewers, editors, staff, or other members of CMSC who are in a position to control content have disclosed no relevant financial relationships.
The planners, reviewers, editors, staff, or other members of PlatformQ Health Education, LLC who are in a position to control content have disclosed no relevant financial relationships.
MEDIA
Internet
METHOD OF PARTICIPATION
To successfully complete this activity, the participant must go to www.Medlive.com. To receive credit, participants must (1) read the activity front matter, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive credit, participants must receive a minimum score of 70% on the post-test
DISCLOSURE OF UNLABELED USE
CMSC and PQHE require faculty to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
DISCLAIMER
CMSC and PQHE present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. CMSC and PQHE, and the commercial supporter(s) assume no liability for the information herein.
PRIVACY POLICY
Please review our privacy policy here: https://www.medlive.com/privacy-policy.
CONTACT INFORMATION
Accreditation and Technical Support:
For any technical issues or issues with your certificate, please contact Medlive at 877-394-1306 or at [email protected].